Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 15, 2022

SELL
$3.5 - $7.2 $60,389 - $124,228
-17,254 Reduced 44.36%
21,642 $139,000
Q1 2022

May 16, 2022

BUY
$6.3 - $8.84 $116,033 - $162,815
18,418 Added 89.94%
38,896 $277,000
Q4 2021

Feb 14, 2022

BUY
$6.02 - $11.43 $15,772 - $29,946
2,620 Added 14.67%
20,478 $171,000
Q3 2021

Nov 15, 2021

BUY
$5.46 - $22.6 $97,504 - $403,590
17,858 New
17,858 $124,000

Others Institutions Holding MCRB

About Seres Therapeutics, Inc.


  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $89.3M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.